Miklos Molnar is a Nephrology physician. OpenAlex indexes 459 publications with 23,829 citations (h-index 73). By OpenAlex citation count, this profile ranks in the top 5% of Nephrology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
601 Elmwood Ave
Rochester, NY 146420001
Telephone
585-273-3881Provider last certified this registry record 3 Jun 2026.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Apellis Pharmaceuticals, Inc.Program year20252 payments
- Amgen Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20246 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
42.4%Beta blocker17%Carvedilol100%Part D≥21 patientsStatin14.9%Atorvastatin Calcium100%Part D≥19 patients+ 1 more class in this area
Metabolism & gastrointestinal
27.2%Corticosteroid20.8%Prednisone100%Part D≥30 patientsH2 blocker6.4%Famotidine100%Part D<11 patientsAnti-infectives
16.1%Short-acting sulfonamides9.4%Sulfamethoxazole-Trimethoprim100%Part D≥16 patientsCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor6.7%Valganciclovir Hcl100%Part D≥16 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
JAMA Internal Medicine
2020 - AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19
Journal of the American Society of Nephrology
2020 - Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States
American Journal of Kidney Diseases
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”